Overexpression of human carcinoma-associated antigen in esophageal adenocarcinoma and its precursor lesions

American Journal of Clinical Pathology

Volumn 122, Issue 5, 2004, Pages 747-751

  Liang, Songlin ^a   Yao, Jorge ^a   Bourne, Patricia A ^a   DiSant'Agnese, P Anthony ^a   Huang, Jiaoti ^a   Lei, Jun Yi ^a  

^a UNIVERSITY OF ROCHESTER MEDICAL CENTER   (United States)

Author keywords

Barrett esophagus; Esophageal adenocarcinoma; HCA; Human carcinoma associated antigen; Immunohistochemistry

Indexed keywords

CANCER ANTIBODY; GLYCOPROTEIN; HUMAN CARCINOMA ASSOCIATED ANTIGEN; MONOCLONAL ANTIBODY; TUMOR ANTIGEN; UNCLASSIFIED DRUG;

ADENOCARCINOMA; ADULT; AGED; ANTIGEN EXPRESSION; ARTICLE; BARRETT ESOPHAGUS; CANCER GRADING; CARCINOGENESIS; CARCINOMA IN SITU; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; DISEASE SEVERITY; DYSPLASIA; ESOPHAGOGASTROSTOMY; ESOPHAGUS CARCINOMA; ESOPHAGUS MUCOSA; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IMMUNOTHERAPY; MALE; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN TARGETING;

EID: 7244227942     PISSN: 00029173     EISSN: None     Source Type: Journal    
DOI: 10.1309/02APA6APGL43GCTR     Document Type: Article

References (29)

1. Blot WJ, McLaughlin JK. The changing epidemiology of esophageal cancer. Semin Oncol. 1999;26:2-8.
2. Powell J, McConkey CC. The rising trend in oesophageal adenocarcinoma and gastric cardia. Eur J Cancer Prev. 1992;1:265-269.
3. Blot WJ, Devesa SS, Fraumeni JF Jr. Continuing climb in rates of esophageal adenocarcinoma: an update [letter]. JAMA. 1993;270:1320.
4. Enzinger PC, Mayer RJ. Esophageal cancer. N Engl J Med. 2003;349:2241-2252.
5. Chen X, Yang CS. Esophageal adenocarcinoma: a review and perspectives on the mechanism of carcinogenesis and chemoprevention. Carcinogenesis. 2001;22:1119-1129.
6. Thingstad T, Haavik S, Hansen K, et al. Human carcinoma - associated antigen (HCA), isolated from the endometrial carcinoma cell line KLE-1 and ascitic fluid of a patient with ovarian carcinoma: comparison with epiglycanin. Eur J Pharm Sci. 1998;6:121-129.
7. Codington JF, Linsley KB, Jeanlot RW. Immunochemical and chemical investigations of the structure of glycoprotein fragments obtained from epiglycanin, a glycoprotein at the surface of the TA3-Ha cancer cell. Carbohydr Res. 1975;40:171-182.
8. Codington JF, Haavik S, Nikrui N, et al. Immunologic quantitation of the carcinoma specific human carcinoma antigen in clinical samples. Cancer. 2002;94:803-813.
9. Codington JF, Bhavanandan VP, Bloch KJ, et al. Antibody to epiglycanin and radioimmunoassay to detect epiglycanin-related glycoproteins in body fluids of cancer patients. J Natl Cancer Inst. 1984;73:1029-1038.
10. Taylor JA, Goluboff ET, Holub W, et al. The human carcinoma antigen: a new biomarker for prostate cancer [abstract]. J Urol. 1999;161(4 suppl):209.
11. Li R, Yang Q, Bourne PA, et al. Frequent expression of human carcinoma - associated antigen (HCA), amucin-type glycoprotein, in cells of prostatic carcinoma. Arch Pathol Lab Med. In press.
12. Yao JL, Bourne PA, Yang Q, et al. Overexpression of human carcinoma - associated antigen in urothelial carcinoma of the bladder. Arch Pathol Lab Med. 2004;128:785-787.
13. Wittel UA, Goel A, Varshney GC, et al. Mucin antibodies: new tools in diagnosis and therapy of cancer. Front Biosci. 2001;6:D1296-D1310.
14. Baldus SE, Hanisch FG. Biochemistry and pathological importance of mucin-associated antigens in gastrointestinal neoplasia. Adv Cancer Res. 2000;79:201-248.
15. Hilkens J, Buijs F, Hilgers J, et al. Monoclonal antibodies against human milk-fat globule membranes detecting differentiation antigens of the mammary gland and its tumors. Int J Cancer. 1984;34:197-206.
16. Price MR, Pugh JA, Hudecz F, et al. C595: a monoclonal antibody against the protein core of human urinary epithelial mucin commonly expressed in breast carcinomas. Br J Cancer. 1990;61:681-686.
17. Dong Y, Walsh MD, Cummings MC, et al. Expression of MUC1 and MUC2 mucins in epithelial ovarian tumors. J Pathol. 1997;183:311-317.
18. McGuckin MA, Walsh MD, Hohn BG, et al. Prognostic significance of MUC1 epithelial mucin expression in breast cancer. Hum Pathol. 1995;26:432-439.
19. Kitamura H, Yonezawa S, Tanaka S, et al. Expression of mucin carbohydrates and core proteins in carcinomas of the ampulla of Vater: their relationship to prognosis. Jpn J Cancer Res. 1996;87:631-640.
20. Sakamoto H, Yonezawa S, Utsunomiya T, et al. Mucin antigen expression in gastric carcinomas of young and old adults. Hum Pathol. 1997;28:1056-1065.
21. Nguyen PL, Niehans GA, Cherwitz DL, et al. Membrane-bound (MUC1) and secretory (MUC2, MUC3, and MUC4) mucin gene expression in human lung cancer. Tumour Biol. 1996;17:176-192.
22. Botti C, Seregni E, Menard S, et al. Two novel monoclonal antibodies against the MUC4 tandem repeat reacting with an antigen overexpressed by lung cancer. Int J Biol Markers. 2000;15:312-320.
23. Hollingsworth MA, Strawhecker JM, Caffrey TC, et al. Expression of MUC1, MUC2, MUC3 and MUC4 mucin mRNAs in human pancreatic and intestinal tumor cell lines. Int J Cancer. 1994;57:198-203.
24. Choudhury A, Moniaux N, Winpenny JP, et al. Human MUC4 mucin cDNA and its variants in pancreatic carcinoma. J Biochem (Tokyo). 2000;128:233-243.
25. Lord RV, Salonga D, Danenberg KD, et al. Telomerase reverse transcriptase expression is increased early in the Barrett's metaplasia, dysplasia, adenocarcinoma sequence. J Gastrointest Surg. 2000;4:135-242.
26. Kato H, Yoshikawa M, Fukai Y, et al. An immunohistochemical study of p16, pRb, p21, and p53 proteins in human esophageal cancers. Anticancer Res. 2000;20:345-349.
27. Van der Woude CJ, Jansen PLM, Tiebosch AEG, et al. Expression of apoptosis-related proteins in Barrett's metaplasia-dysplasia-carcinoma sequence: a switch to a more resistant phenotype. Hum Pathol. 2002;33:686-692.
28. Geddert H, Kiel S, Heep HJ, et al. The role of p63 and deltaNp63 (p40) protein expression and gene amplification in esophageal carcinogenesis. Hum Pathol. 2003;34:850-856.
29. McManus DT, Olaru A, Meltzer SJ. Biomarkers of esophageal adenocarcinoma and Barrett's esophagus. Cancer Res. 2004;64:1561-1569.